New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Eledon Pharmaceuticals, Inc.
ELDN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

155M

Biotechnology

Next Earning date - 11 Nov 2025

155M

Biotechnology

Next Earning date - 11 Nov 2025

2.60USD

Shape-0.03 ( -1.14%)
Market Closed (as of Aug 18, 20:00 EDT)
favorite-chart

Relative Strenght

18
favorite-chart

Volume Buzz

26%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated August 19, 2025
1W 0.00 % 1M -29.54 % 3M -15.03 % 1Y -8.77 %

Key Metrics

Shape
  • Market Cap

    155.39M


  • Shares Outstanding

    59.88M


  • Share in Float

    55.83M


  • Dividende

    0


  • Earning Date

    11 Nov 2025


  • Price Target

    2.595


  • Average Volume

    686270


  • Beta

    -0.143


  • Range

    2.375-5.54


  • Industry

    Biotechnology


  • Website

    https://eledon.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

809.34x

P/S Ratio

1.75x

P/B Ratio

0.0

Debt/Equity

-9920.8%

Net Margin

$-0.0

EPS

How ELDN compares to sector?

P/E Ratio

Relative Strength

Shape

ELDN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

N/A

N/A

2026-Revenue

$0.99

Shape-1135%

2026-EPS

N/A

N/A

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

9.00(246.82%)

Number of analyst

1

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-0.40
vs -0.65

Q3.23

arrow
arrow

N/A

-0.35
vs -0.73

Q4.23

arrow
arrow

N/A

-0.29
vs -0.68

Q1.24

arrow
arrow

N/A

-0.34
vs -0.75

Q2.24

arrow
arrow

N/A

-0.32
vs -0.40

Q3.24

arrow
arrow

N/A

-0.32
vs -0.35

Q4.24

arrow
arrow

N/A

-0.64
vs -0.29

Q1.25

arrow
arrow

N/A

-0.08
vs -0.34

Q2.25

arrow
arrow

N/A

-0.23
vs -0.32

Q3.25

arrow
arrow

N/A

-0.26
vs -0.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-100%

NA  vs 120

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

560K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-66%

192K  vs 560K

Q1.25

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-69%

-0.69
vs -0.07

Q1.23

arrow
arrow

-14%

-0.14
vs -0.69

Q2.23

arrow
arrow

-10%

-0.10
vs -0.14

Q3.23

arrow
arrow

-11%

-0.11
vs -0.10

Q4.23

arrow
arrow

-12%

-0.12
vs -0.11

Q1.24

arrow
arrow

-14%

-0.14
vs -0.12

Q2.24

arrow
arrow

+528%

5.28
vs -0.14

Q3.24

arrow
arrow

+101%

1.01
vs 5.28

Q4.24

arrow
arrow

-38%

-0.38
vs 1.01

Q1.25

arrow
arrow

-6%

-0.06
vs -0.38

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

31

31
vs 28

11%

Q2.23

arrow
arrow

33

33
vs 31

6%

Q3.23

arrow
arrow

28

28
vs 33

-15%

Q4.23

arrow
arrow

29

29
vs 28

4%

Q1.24

arrow
arrow

30

30
vs 29

3%

Q2.24

arrow
arrow

31

31
vs 30

3%

Q3.24

arrow
arrow

33

33
vs 31

6%

Q4.24

arrow
arrow

77

77
vs 33

133%

Q1.25

arrow
arrow

86

86
vs 77

12%

Q2.25

arrow
arrow

88

88
vs 86

2%

Earnings Growth

Latest News